JP5828594B2 - 溶融ピロロカルバゾール誘導体を精製するための方法 - Google Patents
溶融ピロロカルバゾール誘導体を精製するための方法 Download PDFInfo
- Publication number
- JP5828594B2 JP5828594B2 JP2013511294A JP2013511294A JP5828594B2 JP 5828594 B2 JP5828594 B2 JP 5828594B2 JP 2013511294 A JP2013511294 A JP 2013511294A JP 2013511294 A JP2013511294 A JP 2013511294A JP 5828594 B2 JP5828594 B2 JP 5828594B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- complex
- acid
- butanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AEULIVPVIDOLIN-UHFFFAOYSA-N CC(C)C[n](c(ccc(Nc1ncccn1)c1)c1c1c2CN3)c1c(CCc1n[n](C)cc1-1)c-1c2C3=O Chemical compound CC(C)C[n](c(ccc(Nc1ncccn1)c1)c1c1c2CN3)c1c(CCc1n[n](C)cc1-1)c-1c2C3=O AEULIVPVIDOLIN-UHFFFAOYSA-N 0.000 description 3
- RRJFMWRZVZHIAT-UHFFFAOYSA-N CC(C)C[n](c(ccc(Nc1ncccn1)c1)c1c1c2CN3)c1c(ccc1n[n](C)cc11)c1c2C3=O Chemical compound CC(C)C[n](c(ccc(Nc1ncccn1)c1)c1c1c2CN3)c1c(ccc1n[n](C)cc11)c1c2C3=O RRJFMWRZVZHIAT-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34583110P | 2010-05-18 | 2010-05-18 | |
| US61/345,831 | 2010-05-18 | ||
| PCT/US2011/036814 WO2011146488A1 (en) | 2010-05-18 | 2011-05-17 | Method for purifying a fused pyrrolocarbazole derivative |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015205469A Division JP2016074668A (ja) | 2010-05-18 | 2015-10-19 | 溶融ピロロカルバゾール誘導体を精製するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013526573A JP2013526573A (ja) | 2013-06-24 |
| JP2013526573A5 JP2013526573A5 (enExample) | 2014-07-03 |
| JP5828594B2 true JP5828594B2 (ja) | 2015-12-09 |
Family
ID=44168420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013511294A Active JP5828594B2 (ja) | 2010-05-18 | 2011-05-17 | 溶融ピロロカルバゾール誘導体を精製するための方法 |
| JP2015205469A Pending JP2016074668A (ja) | 2010-05-18 | 2015-10-19 | 溶融ピロロカルバゾール誘導体を精製するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015205469A Pending JP2016074668A (ja) | 2010-05-18 | 2015-10-19 | 溶融ピロロカルバゾール誘導体を精製するための方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8884014B2 (enExample) |
| EP (1) | EP2571885B1 (enExample) |
| JP (2) | JP5828594B2 (enExample) |
| KR (1) | KR101815332B1 (enExample) |
| CN (1) | CN102958934B (enExample) |
| AU (1) | AU2011256264B2 (enExample) |
| BR (1) | BR112012029374B1 (enExample) |
| CA (1) | CA2799517C (enExample) |
| CL (1) | CL2012003208A1 (enExample) |
| EA (1) | EA021869B1 (enExample) |
| ES (1) | ES2530015T3 (enExample) |
| IL (2) | IL223016A0 (enExample) |
| MX (1) | MX2012013304A (enExample) |
| MY (1) | MY156830A (enExample) |
| NZ (1) | NZ604135A (enExample) |
| PH (1) | PH12012502250A1 (enExample) |
| SG (2) | SG10201503541WA (enExample) |
| UA (1) | UA108498C2 (enExample) |
| WO (1) | WO2011146488A1 (enExample) |
| ZA (1) | ZA201209305B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103965204B (zh) | 2008-11-19 | 2016-09-07 | 赛福伦公司 | 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7109229B2 (en) * | 2000-09-29 | 2006-09-19 | Eli Lilly And Company | Methods and compounds for treating proliferative diseases |
| US7169802B2 (en) * | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| JP2006241579A (ja) | 2005-03-07 | 2006-09-14 | Nippon Paint Co Ltd | 化成処理剤及び表面処理金属 |
| CN103965204B (zh) * | 2008-11-19 | 2016-09-07 | 赛福伦公司 | 吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式 |
-
2011
- 2011-05-17 PH PH1/2012/502250A patent/PH12012502250A1/en unknown
- 2011-05-17 KR KR1020127032917A patent/KR101815332B1/ko active Active
- 2011-05-17 MX MX2012013304A patent/MX2012013304A/es active IP Right Grant
- 2011-05-17 EA EA201291269A patent/EA021869B1/ru not_active IP Right Cessation
- 2011-05-17 WO PCT/US2011/036814 patent/WO2011146488A1/en not_active Ceased
- 2011-05-17 AU AU2011256264A patent/AU2011256264B2/en active Active
- 2011-05-17 JP JP2013511294A patent/JP5828594B2/ja active Active
- 2011-05-17 ES ES11721691.1T patent/ES2530015T3/es active Active
- 2011-05-17 UA UAA201214484A patent/UA108498C2/ru unknown
- 2011-05-17 MY MYPI2012004977A patent/MY156830A/en unknown
- 2011-05-17 BR BR112012029374-5A patent/BR112012029374B1/pt active IP Right Grant
- 2011-05-17 CA CA2799517A patent/CA2799517C/en active Active
- 2011-05-17 CN CN201180024787.XA patent/CN102958934B/zh active Active
- 2011-05-17 SG SG10201503541WA patent/SG10201503541WA/en unknown
- 2011-05-17 SG SG2012084851A patent/SG185645A1/en unknown
- 2011-05-17 NZ NZ604135A patent/NZ604135A/en unknown
- 2011-05-17 EP EP11721691.1A patent/EP2571885B1/en active Active
-
2012
- 2012-11-13 IL IL223016A patent/IL223016A0/en active IP Right Grant
- 2012-11-16 US US13/678,886 patent/US8884014B2/en active Active
- 2012-11-16 CL CL2012003208A patent/CL2012003208A1/es unknown
- 2012-12-07 ZA ZA2012/09305A patent/ZA201209305B/en unknown
-
2015
- 2015-10-19 JP JP2015205469A patent/JP2016074668A/ja active Pending
- 2015-10-22 IL IL242221A patent/IL242221B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005504086A5 (enExample) | ||
| CN111499640A (zh) | 哌嗪并三唑类衍生物的手性拆分方法 | |
| JP6340471B2 (ja) | アピキサバンの製造方法 | |
| EP3027626A1 (en) | A process for preparing rifaximin k | |
| JP2016074668A (ja) | 溶融ピロロカルバゾール誘導体を精製するための方法 | |
| SI21850A (sl) | Soli olanzapina in njihova pretvorba v prosto bazo olanzapina | |
| CA3226626A1 (en) | Crystal form of compound represented by formula i, and preparation therefor and application thereof | |
| CN114478536A (zh) | 四氢吡嗪稠环衍生物的制备方法 | |
| HK1182100B (en) | Method for purifying a fused pyrrolocarbazole derivative | |
| JP6571497B2 (ja) | ミルタザピンの製造方法 | |
| JP7748370B2 (ja) | トリアゾリンジオン付加体の製造方法 | |
| EP1730153B1 (en) | Isopropanol water solvate of olanzapine | |
| WO2026088971A1 (ja) | ビフェナントレン骨格含有ジヒドロキシ化合物の結晶の製造方法 | |
| JP6008734B2 (ja) | オランザピンｉｉ型結晶の製造方法 | |
| WO2016142173A1 (en) | 4-(2-methyl-1h-imidazol-1-yl)-2,2-diphenylbutanenitrile solid form | |
| WO2026088970A1 (ja) | ビフェナントレン骨格含有ジヒドロキシ化合物を含有する組成物及びその製造方法 | |
| WO2026088969A1 (ja) | ビフェナントレン骨格含有ジヒドロキシ化合物の製造方法 | |
| JP6433809B2 (ja) | １−（３−ヒドロキシメチルピリジル−２−）−２−フェニル−４−メチルピペラジンの製造方法 | |
| TW202540077A (zh) | 具有抗癌活性之ｍｄｍ２－ｐ５３交互作用的異吲哚啉酮抑制劑的中間體的製造方法 | |
| JP2026008769A (ja) | ビナフチル骨格を有するジエステル化合物の結晶混合物及びその製造方法 | |
| US20100179318A1 (en) | Process to make lestaurtinib | |
| JP2010077070A (ja) | イミダゾール誘導体の精製方法 | |
| EA044645B1 (ru) | Способ получения апиксабана | |
| JP2017128551A (ja) | １−（３−ヒドロキシメチルピリジル−２−）−２−フェニル−４−メチルピペラジンの製造方法 | |
| WO2016021524A1 (ja) | 光学活性２－メチルピペラジンの製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140516 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140516 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150324 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150624 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150713 |
|
| TRDD | Decision of grant or rejection written | ||
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20150811 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150818 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150811 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20150911 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150916 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151019 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5828594 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |